2018 AAPM Annual Meeting
Back to session list

Session Title: International Symposium: A Global Perspective: Radiation Effects in Radiology and Nuclear Medicine
Question 1: Which International Organization promotes safe use of ionizing radiation by providing educational material, international educational courses and instructorship to developing countries:
Reference:LONG TERM STRUCTURE OF THE IAEA SAFETY STANDARDS AND CURRENT STATUS https://www-ns.iaea.org/committees/files/CSS/205/status.pdf
Choice A:United Nations
Choice B:United Nations International Children's Emergency Fund (UNICEF)
Choice C:United Nations Educational, Scientific and Cultural Organization (UNESCO)
Choice D:International Atomic Energy Agency (IAEA)
Question 2: What is the magnitude of the effective dose from colonography screening relative to chest screening?
Reference:- Rampinelli C et al (2017), BMJ 356:j347, http://dx.doi.org/10.1136/bmj.j347 - Berrington de González A et al (2011), AJR 196:816-823 - Lee C et al (2017), AJR 208:1-7 - Leidenbaum MH (2008), Eur Radiol 18:2222-2230
Choice A:Lower.
Choice B:About the Same.
Choice C:Higher
Question 3: In neuroradiological interventions using an isocentric fluoroscope, which of the following statements describes the displayed reference air kerma, Ka,r:
Reference:1. NCRP, 2010. Report No. 168 - Radiation Dose Management for Fluoroscopically-Guided Interventional Medical Procedures. Bethesda, MD. 2. Artur Omar et al 2016 . A framework for organ dose estimation in x-ray angiography and interventional radiology based on dose-related data in DICOM structured reports. Phys. Med. Biol. 61 (8) 3063
Choice A:Is defined on the central x-ray beam at a point located 15 cm from the isocenter toward the X-ray tube.
Choice B:Includes backscatter but no forward scatter.
Choice C:Accounts for attenuation wedges in the beam.
Choice D:Is independent of fluoroscopy and image acquisition times.
Question 4: Which of the following special drugs might put some patients at greater risk for radiation injury:
Reference:• Koenig TR, Wolff D, Mettler FA et al. Skin injuries from fluoroscopically guided procedures: part 1, characteristics of radiation injury. AJR Am J Roentgenol 2001; 177(1):3-11. • Hall EJ. Radiobiology for the radiologist. 5th edition. Philadelphia: Lippincott Williams & Wilkins, 2000.
Choice A:Angiotensin-converting enzyme (ACE) inhibitors.
Choice B:Corticosteroids.
Choice C:Actinomycin D.
Question 5: For Hybrid imaging such as PET/CCT and SPECT/CT, what is effect of the CT scan on overall radiation exposure to a patient?
Reference:• Willowson KP, Bailey EA, Bailey DL. A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT. Australas Phys Eng Sci Med. 2012;35(1):49-53. • Bailey DL, Roach PJ, Bailey EA, Hewlett J, Keijzers R. Development of a cost-effective modular SPECT/CT scanner. Eur J Nucl Med Mol Imaging. 2007;34(9):1415-26.
Choice A:Hardly affected.
Choice B:Approximately doubled.
Choice C:Increased greatly.
Choice D:Decreased as less radiopharmaceutical is needed.
Question 6: The organ usually considered at greatest risk in radionuclide therapy treatments using alpha or beta emitters is:
Reference:• Dale RG, Wondergem J. Chapter 2. Basic Radiobiology. In: Bailey DL, Humm JL, Todd-Pokropek A, Van Aswegen A, editors. Nuclear Medicine Physics; A Handbook for Teachers and Students. Vienna: IAEA; 2014. p. 49-75. (Available online and free). • McParland BJ. Nuclear Medicine Radiation Dosimetry. London: Springer; 2011. 610 pp.
Choice A:Heart.
Choice B:Kidney.
Choice C:Liver.
Choice D:Bone marrow.
Back to session list